UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bioinformatics and breast cancer: what can high-throughput genomic approaches actually tell us?

Journal of Clinical Pathology, 2009-10, Vol.62 (10), p.879-885

Sims, A H

2009

Volltextzugriff (PDF)

Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer

British journal of cancer, 2012-05, Vol.106 (11), p.1779-1789

2012

Volltextzugriff (PDF)

A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk

British journal of cancer, 2010-07, Vol.103 (3), p.401-410

2010

Volltextzugriff (PDF)

Changes in PIK3CA mutation status are not associated with recurrence, metastatic disease or progression in endocrine-treated breast cancer

Breast cancer research and treatment, 2014-08, Vol.147 (1), p.211-219

2014

Volltextzugriff (PDF)

Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue

Endocrine-related cancer, 2006-06, Vol.13 (2), p.617-628

2006

Volltextzugriff (PDF)

KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals

Oncogene, 2013-04, Vol.32 (14), p.1821-1830

2013

Volltextzugriff (PDF)

Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response

BMC cancer, 2014-02, Vol.14 (1), p.119-119, Article 119

2014

Volltextzugriff (PDF)

TPD52 and NFKB1 gene expression levels correlate with G2 chromosomal radiosensitivity in lymphocytes of women with and at risk of hereditary breast cancer

International journal of radiation biology, 2007-01, Vol.83 (6), p.409-420

2007

Volltextzugriff (PDF)

Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance

Cancer research (Chicago, Ill.), 2015-04, Vol.75 (7), p.1457-1469

2015

Volltextzugriff (PDF)

Monocytes and macrophages, implications for breast cancer migration and stem cell-like activity and treatment

Oncotarget, 2015-06, Vol.6 (16), p.14687-14699

2015

Volltextzugriff (PDF)

50PER pathway activity score as a predictive biomarker to improve stratification for neoadjuvant endocrine therapy

Annals of oncology, 2019-05, Vol.30 (Supplement_3)

2019

Volltextzugriff (PDF)

284PChanges in ER pathway activity score during neoadjuvant letrozole to assess therapy response and predict disease free survival (DFS) in ER positive breast cancer patients

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

ER pathway activity score as a predictive biomarker to improve stratification for neoadjuvant endocrine therapy

Annals of oncology, 2019-05, Vol.30, p.iii16-iii16

2019

Volltextzugriff (PDF)

EVIDENCE FOR AN INCREASED RISK FOR HYPERTENSION WITH CENTRALLY LOCATED BODY FAT AND THE EFFECT OF RACE AND SEX ON THIS RISK

American journal of epidemiology, 1984-04, Vol.119 (4), p.526-540

1984

Volltextzugriff (PDF)

Are there persons who are obese, but metabolically healthy?

Metabolism, 2001-12, Vol.50 (12), p.1499-1504

Sims, Ethan A.H.

2001

Volltextzugriff (PDF)

Orthopedic Surgical Oncology for Bone Tumors: A Case Study Atlas

1st Edition 2022, 2021

Volltextzugriff (PDF)

Cyclin D1, Id1 and EMT in breast cancer

BMC cancer, 2011-09, Vol.11 (1), p.417-417, Article 417

2011

Volltextzugriff (PDF)

Abstract P5-04-28: A potential role for IL6ST mediating endocrine resistance in breast cancer via interaction with the ER signaling pathway

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P5-P5-04-28

2019

Volltextzugriff (PDF)

Abstract P3-11-09: Not presented

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P3-P3-11-09

2019

Volltextzugriff (PDF)

Abstract P3-11-13: On-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P3-P3-11-13

2019

Volltextzugriff (PDF)

What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?

The journal of clinical endocrinology and metabolism, 2001-03, Vol.86 (3), p.1020-1025

2001

Volltextzugriff (PDF)

Abstract P5-04-03: Molecular characterisation of ER+ breast cancer dormancy and acquired resistance using a clinical model: Potential involvement of epigenetic regulation

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P5-P5-04-03

2019

Volltextzugriff (PDF)

Abstract P5-11-03: Measurement of on-treatment proliferation biomarkers in nodal metastasis improves prediction of endocrine therapy response using the EA2CliN test

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P5-P5-11-03

2019

Volltextzugriff (PDF)

Abstract P4-08-03: EA2Clin: A novel immunohistochemical prognostic and predictive test for patients with estrogen receptor-Positive breast cancer

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P4-P4-08-03

2018

Volltextzugriff (PDF)

Abstract P5-04-27: Investigating the incidence of ESR1 gene amplification in breast cancers resistant to multiple endocrine agents

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P5-P5-04-27

2019

Volltextzugriff (PDF)

1 – 25 von 3.784

Suche als RSS-Feed

Aktive Filter

SpracheFranzösisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.978)
Mit Volltextzugriff
(3.093)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(3.768)
Spanisch
(5)
Deutsch
(4)
Japanisch
(3)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.933)
Life Sciences & Biomedicine
(1.478)
Humans
(1.075)
Female
(651)
Male
(536)
Biological And Medical Sciences
(492)
Animals
(416)
Adult
(357)
Middle Aged
(313)
Physical Sciences
(276)
Medical Sciences
(275)
Technology
(272)
Fundamental And Applied Biological Sciences. Psychology
(240)
Aged
(223)
Social Sciences
(204)
Exact Sciences And Technology
(165)
Biochemistry & Molecular Biology
(161)
Mice
(157)
Adolescent
(137)
General & Internal Medicine
(131)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.462)
EZB Electronic Journals Library
(1.362)
IngentaConnect
(1.225)
Journals@Ovid
(1.059)
NUS Single-Journal Subscriptions
(851)
Elsevier ScienceDirect Journals Complete
(592)
Wiley Online Library Journals
(450)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(435)
IngentaConnect Journals
(435)
Ebook Central Perpetual and DDA
(336)
eBooks on EBSCOhost
(325)
JSTOR
(297)
Wiley Online Library
(277)
SpringerLink
(237)
Oxford journals
(183)
SAGE Publications
(133)
Nature Journals
(122)
Taylor & Francis
(112)
Taylor & Francis Journals
(108)
Business Source Ultimate【Trial: -2024/12/31】【Remote access available】
(104)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Bioinformatics and breast cancer: what can high-throughput genomic approaches actually tell us?

Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer

A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk

Changes in PIK3CA mutation status are not associated with recurrence, metastatic disease or progression in endocrine-treated breast cancer

Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue

KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals

Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response

TPD52 and NFKB1 gene expression levels correlate with G2 chromosomal radiosensitivity in lymphocytes of women with and at risk of hereditary breast cancer

Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance

Monocytes and macrophages, implications for breast cancer migration and stem cell-like activity and treatment

50PER pathway activity score as a predictive biomarker to improve stratification for neoadjuvant endocrine therapy

284PChanges in ER pathway activity score during neoadjuvant letrozole to assess therapy response and predict disease free survival (DFS) in ER positive breast cancer patients

ER pathway activity score as a predictive biomarker to improve stratification for neoadjuvant endocrine therapy

EVIDENCE FOR AN INCREASED RISK FOR HYPERTENSION WITH CENTRALLY LOCATED BODY FAT AND THE EFFECT OF RACE AND SEX ON THIS RISK

Are there persons who are obese, but metabolically healthy?

Orthopedic Surgical Oncology for Bone Tumors: A Case Study Atlas

Cyclin D1, Id1 and EMT in breast cancer

Abstract P5-04-28: A potential role for IL6ST mediating endocrine resistance in breast cancer via interaction with the ER signaling pathway

Abstract P3-11-09: Not presented

Abstract P3-11-13: On-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancer

What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?

Abstract P5-04-03: Molecular characterisation of ER+ breast cancer dormancy and acquired resistance using a clinical model: Potential involvement of epigenetic regulation

Abstract P5-11-03: Measurement of on-treatment proliferation biomarkers in nodal metastasis improves prediction of endocrine therapy response using the EA2CliN test

Abstract P4-08-03: EA2Clin: A novel immunohistochemical prognostic and predictive test for patients with estrogen receptor-Positive breast cancer

Abstract P5-04-27: Investigating the incidence of ESR1 gene amplification in breast cancers resistant to multiple endocrine agents

Aktive Filter

Suchergebnisse filtern